White label – Pompe disease - ClinicalTrials.eu

Study of ACP-017 and Pembrolizumab for Patients with Advanced or Metastatic Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Neoplasm malignant
- Neoplasm
Investigated Drugs:
- Acp-017
- Pembrolizumab
Study of Axitinib and Pembrolizumab for Patients with Advanced or Metastatic Papillary Renal Cell Carcinoma

Not recruiting

2 1 1 1
Investigated Drugs:
- Axitinib
- Pembrolizumab
Study on Quercus ilex and Quercus robur Allergen Extracts for Patients with Oak Pollen Allergy

Not recruiting

2 1 1
Investigated Drugs:
Study on the Effects of Ertugliflozin and Sodium Intake on Blood Pressure in Overweight Adults with Type 2 Diabetes

Not recruiting

3 1 1 1
Investigated Diseases:
- Type 2 diabetes mellitus
Investigated Drugs:
- Ertugliflozin
Study on the Safety and Effects of TNG908 in Patients with Advanced or Metastatic Solid Tumors Missing the MTAP Gene

Not recruiting

2 1 1 1
Investigated Drugs:
- Dobutamine Hydrochloride
- N-(6-Amino-5-Methylpyridin-3-Yl)-2-((2R,5S)-2-(Benzo[D]Thiazol-5-Yl)-5-Methylpiperidin-1-Yl)-2-Oxoacetamide
Title: Long-term safety study of N-Acetyl-GED-0507-34-LEVO gel 5% applied to the skin for patients with acne vulgaris

Not recruiting

3 1 1
Investigated Drugs:
- (S)-3-(4-Acetamidophenyl)-2-Methoxypropanoic Acid
Study on Amivantamab, Lazertinib, and Bevacizumab for Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer After Treatment Progression

Not recruiting

2 1 1 1
Investigated Diseases:
- EGFR gene mutation
- Non-small cell lung cancer
Investigated Drugs:
Study of Ponatinib for Patients with Resistant Chronic Myeloid Leukemia

Not recruiting

2 1 1 1
Investigated Diseases:
- Chronic myeloid leukaemia
Investigated Drugs:
- Ponatinib
Study on Testosterone Undecanoate for Neuroprotection and Myelin Repair in Patients with Relapsing Remitting Multiple Sclerosis

Not recruiting

2 1 1
Investigated Drugs:
- Testosterone Undecanoate
Study on the Safety and Effectiveness of Aticaprant with Antidepressants for Adults and Elderly with Major Depressive Disorder

Not recruiting

3 1 1
Investigated Diseases:
- Major depression
Investigated Drugs:
- Aticaprant
+5

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies